Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection (Q30396672)

21 June 2017

title

Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection (English)

1 reference

21 June 2017

0 references

A Rhodes

3

0 references

Jordi Rello

object named as

J Rello

13

0 references

0 references

0 references

I Martin-Loeches

1

1 reference

21 June 2017

T Lisboa

2

1 reference

21 June 2017

R P Moreno

4

1 reference

21 June 2017

E Silva

5

1 reference

21 June 2017

C Sprung

6

1 reference

21 June 2017

J D Chiche

7

1 reference

21 June 2017

D Barahona

8

1 reference

21 June 2017

M Villabon

9

1 reference

21 June 2017

C Balasini

10

1 reference

21 June 2017

R M Pearse

11

1 reference

21 June 2017

R Matos

12

1 reference

21 June 2017

ESICM H1N1 Registry Contributors

14

1 reference

21 June 2017

ESICM H1N1 Registry Contributors

15

1 reference

21 June 2017

publication date

24 November 2010

1 reference

21 June 2017

published in

Intensive Care Medicine

1 reference

21 June 2017

volume

37

1 reference

21 June 2017

issue

2

1 reference

21 June 2017

page(s)

272-283

1 reference

Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Nonventilatory treatments for acute lung injury and ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Critically Ill patients with 2009 influenza A(H1N1) in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Corticosteroids for H1N1 associated acute lung injury: is it just wishful thinking?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Safety and efficacy of corticosteroids for the treatment of septic shock: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Human immunopathogenesis of severe acute respiratory syndrome (SARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Hydrocortisone therapy for patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Effects of systemic steroids in patients with severe community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-010-2078-Z

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

12 December 2020

Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation.

1 reference

12 December 2020

Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock

1 reference

12 December 2020

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

1 reference

12 December 2020

Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome

1 reference

12 December 2020

Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine

1 reference

12 December 2020

Glucocorticoid in the treatment of severe acute respiratory syndrome patients: a preliminary report

1 reference

12 December 2020

High-dose corticosteroids in patients with the adult respiratory distress syndrome

1 reference

12 December 2020

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

1 reference

12 December 2020

Compartmentalized cytokine production within the human lung in unilateral pneumonia

1 reference

12 December 2020

Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study

1 reference

12 December 2020

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

1 reference

12 December 2020

Eosinophilic alveolitis in acute respiratory failure. A clinical marker for a non-infectious etiology

1 reference

12 December 2020

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

1 reference

12 December 2020

Corticosteroid effects on cell signalling

1 reference

12 December 2020

Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial

1 reference

12 December 2020

Update: outbreak of severe acute respiratory syndrome--worldwide, 2003

1 reference

12 December 2020

Pandemic (H1N1) 2009 influenza ("swine flu") in Australian and New Zealand intensive care.

1 reference

12 December 2020

H1N1 2009 influenza virus infection during pregnancy in the USA.

1 reference

12 December 2020

10.1007/S00134-010-2078-Z

Identifiers

DOI

1 reference

21 June 2017

1 reference